BNP Paribas Financial Markets’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.7K Sell
7,751
-19,342
-71% -$74.1K ﹤0.01% 3633
2025
Q1
$156K Buy
27,093
+20,738
+326% +$119K ﹤0.01% 3025
2024
Q4
$31.7K Sell
6,355
-7,874
-55% -$39.3K ﹤0.01% 3737
2024
Q3
$76.7K Buy
14,229
+10,201
+253% +$55K ﹤0.01% 2802
2024
Q2
$13.3K Sell
4,028
-21,250
-84% -$70.3K ﹤0.01% 3017
2024
Q1
$82.7K Buy
25,278
+4,797
+23% +$15.7K ﹤0.01% 2817
2023
Q4
$71.9K Sell
20,481
-47,460
-70% -$167K ﹤0.01% 2763
2023
Q3
$454K Buy
67,941
+8,122
+14% +$54.3K ﹤0.01% 2126
2023
Q2
$502K Buy
+59,819
New +$502K ﹤0.01% 1995
2023
Q1
Sell
-53
Closed -$369 3212
2022
Q4
$369 Sell
53
-593
-92% -$4.13K ﹤0.01% 3219
2022
Q3
$3.45K Sell
646
-1,554
-71% -$8.3K ﹤0.01% 3574
2022
Q2
$8.78K Sell
2,200
-5,268
-71% -$21K ﹤0.01% 3120
2022
Q1
$33.2K Sell
7,468
-2,468
-25% -$11K ﹤0.01% 3067
2021
Q4
$39.7K Buy
9,936
+1,272
+15% +$5.09K ﹤0.01% 3134
2021
Q3
$76.1K Buy
8,664
+6,821
+370% +$59.9K ﹤0.01% 2791
2021
Q2
$20.9K Sell
1,843
-30,049
-94% -$340K ﹤0.01% 2925
2021
Q1
$379K Buy
+31,892
New +$379K ﹤0.01% 2193
2020
Q4
Sell
-1,257
Closed -$9.31K 3482
2020
Q3
$9.31K Sell
1,257
-36,326
-97% -$269K ﹤0.01% 3341
2020
Q2
$157K Buy
37,583
+30,484
+429% +$127K ﹤0.01% 1982
2020
Q1
$17.5K Buy
7,099
+3,287
+86% +$8.12K ﹤0.01% 3321
2019
Q4
$22.1K Buy
3,812
+378
+11% +$2.2K ﹤0.01% 3298
2019
Q3
$18.1K Buy
3,434
+856
+33% +$4.51K ﹤0.01% 3345
2019
Q2
$15.5K Sell
2,578
-1,812
-41% -$10.9K ﹤0.01% 3362
2019
Q1
$39.6K Buy
+4,390
New +$39.6K ﹤0.01% 3043
2018
Q4
Sell
-521
Closed -$7.19K 3650
2018
Q3
$7.19K Hold
521
﹤0.01% 3229
2018
Q2
$4.14K Buy
+521
New +$4.14K ﹤0.01% 3495